Cancer

The FDA has granted fast track designation to topically applied ATR-04 for the treatment of moderate to severe epidermal growth factor receptor inhibitor-associated dermal toxicity, Azitra announced in a press release.

Fewer cancer drugs were exempt from pediatric testing requirements after the Research to Accelerate Cures and Equity, or RACE, for Children Act went into effect in 2020, a study showed.

The Inflation Reduction Act’s cap on out-of-pocket spending saved patients with cancer more than $7,000 a year on oral chemotherapy medications, a research letter analysis published in JAMA Network Open showed.

Less than three in 10 women are aware that a healthy diet can help reduce the risk for breast cancer, according to a recent survey.

The FDA has not approved a new sunscreen ingredient since the 1990s, leaving consumers and clinicians wondering why.

Menopause onset before age 40 years appears to negate a longevity benefit women typically have over men, particularly among women who also undergo hormone therapy, researchers reported.

The FDA has cleared an investigational new drug application for a first-in-human phase 1/2 study of ATR-04 for moderate to severe dermal toxicity from epidermal growth factor receptor inhibitors, Azitra Inc. announced in a press release.

A 45-year-old woman with a medical history of breast cancer status post mastectomy presented to Lahey Eye Clinic due to 2 weeks of blurry vision, described as a “haze over her eyes.”

Low levels of alcohol consumption may be associated with increased mortality risk in adults with health-related or socioeconomic risk factors, results from a recent analysis suggested.

Use of explainable machine learning combined with an AI classifier can aid health care providers in making accurate diagnoses and identifying root causes of chronic kidney disease at early stages, research data show.